Alimera Sciences to Present at the LD Micro Invitational XII Conference
Alimera Sciences (Nasdaq: ALIM) announced that President and CEO Rick Eiswirth will present a corporate overview at the LD Micro Invitational XII Conference on June 7, 2022, at 9:30am PDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alimera Sciences (Nasdaq: ALIM) announced that President and CEO Rick Eiswirth will present a corporate overview at the LD Micro Invitational XII Conference on June 7, 2022, at 9:30am PDT. The conference will take place from June 7 to 9, 2022, at the Four Seasons in Westlake Village, CA. Mr. Eiswirth will also be available for one-on-one meetings with registered attendees. Alimera is committed to improving retinal health and enhancing vision for patients and their healthcare partners.
Details
News Market Reaction – ALIM
The recorded move for ALIM in the trading session of this news was +3.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTA, June 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the LD Micro Invitational XII Conference. The conference is being held on June 7 – 9, 2022 at the Four Seasons in Westlake Village, CA.
| Presentation Date: | June 7, 2022 | |
| Time: | 9:30am (PDT) | |
| Webcast Link: | LDinv12.mysequire.com |
Mr. Eiswirth will be available for one-on-one meetings with registered attendees of the conference.
About Alimera
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Cindy Rizzo for Alimera ir@alimerasciences.com | For investor inquiries: Scott Gordon for Alimera scottg@coreir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.